Arrivent Biopharma News and Activities

Presence

Arrivent Biopharma develops cancer medicines and related drug development services. Its product focus includes targeted therapies and clinical programs for patients, healthcare providers, and partners in oncology care.

Arrivent Biopharma products and services overview:

Cancer therapies
Targeted medicines
Clinical development
Drug licensing

Revenue: ~$0 million

Employees: 60

Headquarters: Newtown Square, United States (USA)

Arrivent Biopharma is one of the...

Arrivent Biopharma is a company listed under the stock ticker AVBP (US).

Executives

View the org chart displaying its 24 main executives

Most searched biographies at Arrivent Biopharma

Popular executive movements at Arrivent Biopharma

Janet Gee has joined the company as Associate Director, Financial Planning and Analysis (posted on April 22 2026).
Laura Iorio who was Senior Human Resources Manager, becomes Associate Director, Human Resources (posted on April 3 2026).
Brent Rice has joined the company as Chief Commercial Officer (posted on September 23 2025).

Create your alert
to follow the executive moves at Arrivent Biopharma.